Literature DB >> 2444981

Transcriptional control of the endogenous MYC protooncogene by antisense RNA.

K Yokoyama1, F Imamoto.   

Abstract

A plasmid carrying antisense human MYC DNA and the gene encoding Escherichia coli xanthine/guanine phosphoribosyltransferase (Ecogpt) was introduced into human promyelocytic leukemia cell line HL-60 by protoplast fusion. High-level expression of antisense MYC RNA was obtained by selecting cells resistant to progressively higher levels of mycophenolic acid over a period of greater than 6 months. The constitutive production of MYC protein in clones producing high levels of antisense MYC RNA was reduced by 70% compared to parental HL-60 cells. Inhibition of MYC expression was observed not only at the translational but also at the transcriptional level, implying that antisense RNA can regulate transcription of the MYC gene. The Pst I-Pvu II fragment (920 base pairs) of the MYC leader sequence is the primary transcriptional target of the antisense RNA. The suppression of endogenous MYC gene expression by antisense RNA decreases cell proliferation and triggers monocytic differentiation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2444981      PMCID: PMC299296          DOI: 10.1073/pnas.84.21.7363

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Constitutive and conditional suppression of exogenous and endogenous genes by anti-sense RNA.

Authors:  J G Izant; H Weintraub
Journal:  Science       Date:  1985-07-26       Impact factor: 47.728

2.  Cell-type specificity of immunoglobulin gene expression is regulated by at least three DNA sequence elements.

Authors:  R Grosschedl; D Baltimore
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

3.  A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells.

Authors:  D L Bentley; M Groudine
Journal:  Nature       Date:  1986 Jun 12-18       Impact factor: 49.962

4.  Participation of c-myc protein in DNA synthesis of human cells.

Authors:  G P Studzinski; Z S Brelvi; S C Feldman; R A Watt
Journal:  Science       Date:  1986-10-24       Impact factor: 47.728

5.  Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells.

Authors:  S R Hann; R N Eisenman
Journal:  Mol Cell Biol       Date:  1984-11       Impact factor: 4.272

6.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

7.  Activation of the c-myc gene by translocation: a model for translational control.

Authors:  H Saito; A C Hayday; K Wiman; W S Hayward; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

8.  Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.

Authors:  S Murao; M A Gemmell; M F Callaham; N L Anderson; E Huberman
Journal:  Cancer Res       Date:  1983-10       Impact factor: 12.701

9.  Stable reduction of thymidine kinase activity in cells expressing high levels of anti-sense RNA.

Authors:  S K Kim; B J Wold
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

10.  Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells.

Authors:  C V Hall; P E Jacob; G M Ringold; F Lee
Journal:  J Mol Appl Genet       Date:  1983
View more
  36 in total

1.  A rapid genetic screening system for identifying gene-specific suppression constructs for use in human cells.

Authors:  G M Arndt; M Patrikakis; D Atkins
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

2.  Early proto-oncogene expression in rat aortic smooth muscle cells following endothelial removal.

Authors:  J M Miano; R R Tota; N Vlasic; K J Danishefsky; M B Stemerman
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

3.  The leucine zipper of c-Myc is required for full inhibition of erythroleukemia differentiation.

Authors:  M J Smith; D C Charron-Prochownik; E V Prochownik
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

4.  Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells.

Authors:  M D Sklar; E Thompson; M J Welsh; M Liebert; J Harney; H B Grossman; M Smith; E V Prochownik
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

5.  Inhibition of flower pigmentation by antisense CHS genes: promoter and minimal sequence requirements for the antisense effect.

Authors:  A R van der Krol; L A Mur; P de Lange; J N Mol; A R Stuitje
Journal:  Plant Mol Biol       Date:  1990-04       Impact factor: 4.076

6.  Inhibition of Moloney murine leukemia virus-induced leukemia in transgenic mice expressing antisense RNA complementary to the retroviral packaging sequences.

Authors:  L Han; J S Yun; T E Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

7.  Inhibition of SV40 gene expression by microinjected small antisense RNA and DNA molecules.

Authors:  M Graessmann; G Michaels; B Berg; A Graessmann
Journal:  Nucleic Acids Res       Date:  1991-01-11       Impact factor: 16.971

8.  Antisense c-myc effects on preimplantation mouse embryo development.

Authors:  B C Paria; S K Dey; G K Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

9.  c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets.

Authors:  A Bush; M Mateyak; K Dugan; A Obaya; S Adachi; J Sedivy; M Cole
Journal:  Genes Dev       Date:  1998-12-15       Impact factor: 11.361

10.  The human cut homeodomain protein represses transcription from the c-myc promoter.

Authors:  D Dufort; A Nepveu
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.